Abstract
Abstract
Background
Patients undergoing open abdominopelvic procedures for malignancy are at high risk of postoperative venous thromboembolism (VTE). This risk can be mitigated with prophylaxis; however, optimum duration in this population remains unknown. Our objective was to conduct a systematic review of contemporary literature on the use of heparin thromboprophylaxis following major open pelvic surgery for malignancy, comparing the efficacy and safety of extended duration to inpatient treatment.
Methods
A study protocol describing search strategy and inclusion and exclusion criteria was developed and registered with PROSPERO. A literature review was conducted in accordance with the protocol.
Results
Literature review identified only 4 studies directly comparing extended and inpatient duration prophylaxis, with a combined population of 3198 and 3135 patients for VTE rate and bleeding events, respectively. Despite many studies reporting lower VTE rates in patients receiving extended prophylaxis, no statistically significant difference in rates of postoperative VTE (p = 0.18) or bleeding complications (p = 0.43) was identified between patients receiving extended duration prophylaxis and those receiving inpatient only prophylaxis.
Conclusion
On the review of contemporary literature, no significant difference was found in rates of postoperative VTE or bleeding complications between patients receiving extended duration heparin VTE prophylaxis and those receiving inpatient prophylaxis after open abdominopelvic surgery for malignancy.
This raises the question of how extended duration prophylaxis has become common practice in this population, and whether this needs to be re-evaluated.
Funder
Adelaide Research and Innovation, University of Adelaide
Publisher
Springer Science and Business Media LLC
Reference22 articles.
1. Akl E, Terrenato I, Barba M, Sperati F, Muti P, Schunemann HJ. Extended perioperative thromboprophylaxis in patients with cancer. A systematic review. Thromb Haemost. 2008;100:1176–80.
2. American Urological Association. Best practice policy statement for the prevention of deep vein thrombosis in patients undergoing urologic surgery [Internet]. American Urological Association; 2013 [cited 2013 November 7]. Available from: http://www.auanet.org/education/guidelines/deep-vein-thrombosis.cfm (Archived)
3. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2019
4. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against thromboembolism with enoxaparin after surgery for cancer. NEJM. 2002;346:975–80.
5. Beyer J, Wessela S, Halenberg OW, et al. Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery. J Thromb Haemost. 2009;7:597–604.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献